dc.contributor.author |
Rosenthal V.D. |
dc.contributor.author |
Rodrigues C. |
dc.contributor.author |
Alvarez-Moreno C. |
dc.contributor.author |
Madani N. |
dc.contributor.author |
Mitrev Z. |
dc.contributor.author |
Ye G. |
dc.contributor.author |
Salomao R. |
dc.contributor.author |
Ulger F. |
dc.contributor.author |
Guanche-Garcell H. |
dc.contributor.author |
Kanj S.S. |
dc.contributor.author |
Cuellar L.E. |
dc.contributor.author |
Higuera F. |
dc.contributor.author |
Mapp T. |
dc.contributor.author |
Fernandez-Hidalgo R. |
dc.contributor.editor |
|
dc.date |
Dec-2012 |
dc.date.accessioned |
2017-10-05T15:39:55Z |
dc.date.available |
2017-10-05T15:39:55Z |
dc.date.issued |
2012 |
dc.identifier |
10.1097/CCM.0b013e3182657916 |
dc.identifier.isbn |
|
dc.identifier.issn |
00903493 |
dc.identifier.uri |
http://hdl.handle.net/10938/17144 |
dc.description.abstract |
ObjectiveS:: The aim of this study was to analyze the effect of the International Nosocomial Infection Control Consortium's multidimensional approach on the reduction of ventilator-associated pneumonia in patients hospitalized in intensive care units. DESIGN:: A prospective active surveillance before-after study. The study was divided into two phases. During phase 1, the infection control team at each intensive care unit conducted active prospective surveillance of ventilator-associated pneumonia by applying the definitions of the Centers for Disease Control and Prevention National Health Safety Network, and the methodology of International Nosocomial Infection Control Consortium. During phase 2, the multidimensional approach for ventilator-associated pneumonia was implemented at each intensive care unit, in addition to the active surveillance. SETTING:: Forty-four adult intensive care units in 38 hospitals, members of the International Nosocomial Infection Control Consortium, from 31 cities of the following 14 developing countries: Argentina, Brazil, China, Colombia, Costa Rica, Cuba, India, Lebanon, Macedonia, Mexico, Morocco, Panama, Peru, and Turkey. PATIENTS:: A total of 55,507 adult patients admitted to 44 intensive care units in 38 hospitals. INTERVENTIONS:: The International Nosocomial Infection Control Consortium ventilator-associated pneumonia multidimensional approach included the following measures: 1) bundle of infection-control interventions; 2) education; 3) outcome surveillance; 4) process surveillance; 5) feedback of ventilator-associated pneumonia rates; and 6) performance feedback of infection-control practices. MEASUREMENTS:: The ventilator-associated pneumonia rates obtained in phase 1 were compared with the rates obtained in phase 2. We performed a time-series analysis to analyze the impact of our intervention. MAIN RESULT:: During phase 1, we recorded 10,292 mechanical ventilator days, and during phase 2, with the implementation of the multidimensional approach, we recorded 127,374 mechanical ventilator days. The rate of ventilator-associated pneumonia was 22.0 per 1,000 mechanical ventilator days during phase 1, and 17.2 per 1,000 mechanical ventilator days during phase 2.The adjusted model of linear trend shows a 55.83percent reduction in the rate of ventilator-associated pneumonia at the end of the study period; that is, the ventilator-associated pneumonia rate was 55.83percent lower than it was at the beginning of the study. CONCLUSION:: The implementation the International Nosocomial Infection Control Consortium multidimensional approach for ventilator-associated pneumonia was associated with a significant reduction in the ventilator-associated pneumonia rate in the adult intensive care units setting of developing countries. © 2012 by the Society of Critical Care Medicine and Lippincott Williams and Wilkins. |
dc.format.extent |
|
dc.format.extent |
Pages: (3121-3128) |
dc.language |
English |
dc.publisher |
PHILADELPHIA |
dc.relation.ispartof |
Publication Name: Critical Care Medicine; Publication Year: 2012; Volume: 40; no. 12; Pages: (3121-3128); |
dc.relation.ispartofseries |
|
dc.relation.uri |
|
dc.source |
Scopus |
dc.subject.other |
|
dc.title |
Effectiveness of a multidimensional approach for prevention of ventilator-associated pneumonia in adult intensive care units from 14 developing countries of four continents: Findings of the International Nosocomial Infection Control Consortium |
dc.type |
Article |
dc.contributor.affiliation |
Rosenthal, V.D., Infection Control Department (VDR), International Nosocomial Infection Control Consortium, Buenos Aires, Argentina |
dc.contributor.affiliation |
Rodrigues, C., Infection Control Department, PD Hinduja National Hospital, Medical Research Centre, Mumbai, India |
dc.contributor.affiliation |
Álvarez-Moreno, C., Infection Control Department, Hospital Universitario San Ignacio, Universidad Pontificia Javeriana, Bogotá, Colombia |
dc.contributor.affiliation |
Madani, N., Infection Control Department, Ibn Sina-Medical ICU, Rabat, Morocco |
dc.contributor.affiliation |
Mitrev, Z., Infection Control Department, Filip II Special Hospital for Surgery, Skopje, Macedonia |
dc.contributor.affiliation |
Ye, G., Infection Control Department, Yangpu Hospital, Shanghai, China |
dc.contributor.affiliation |
Salomao, R., Infection Control Department, Hospital Santa Marcelina, São Paulo, Brazil |
dc.contributor.affiliation |
Ulger, F., Infection Control Department, Ondokuz Mayis University Medical School, Samsun, Turkey |
dc.contributor.affiliation |
Guanche-Garcell, H., Infection Control Department, Hospital Docente Clinico Quirurgico Joaquin Albarran Dominguez, Havana, Cuba |
dc.contributor.affiliation |
Kanj, S.S., Infection Control Department, American University, Beirut Medical Center, Beirut, Lebanon |
dc.contributor.affiliation |
Cuéllar, L.E., Infection Control Department, Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima, Peru |
dc.contributor.affiliation |
Higuera, F., Infection Control Department, Hospital General de México, Mexico City, Mexico |
dc.contributor.affiliation |
Mapp, T., Infection Control Department, Clínica Hospital San Fernando, Panama City, Panama |
dc.contributor.affiliation |
Fernández-Hidalgo, R., Infection Control Department, Hospital Clínica Bíblica, San José, Costa Rica |
dc.contributor.authorAddress |
Rosenthal, V.D.; Infection Control Department (VDR), International Nosocomial Infection Control Consortium, Buenos Aires, Argentina; email: victor_rosenthal@inicc.org |
dc.contributor.authorCorporate |
University: American University of Beirut Medical Center; Faculty: Faculty of Medicine; Department: Internal Medicine; Division: Infectious Diseases; |
dc.contributor.authorDepartment |
Internal Medicine |
dc.contributor.authorDivision |
Infectious Diseases |
dc.contributor.authorEmail |
victor_rosenthal@inicc.org |
dc.contributor.faculty |
Faculty of Medicine |
dc.contributor.authorInitials |
Rosenthal, VD |
dc.contributor.authorInitials |
Rodrigues, C |
dc.contributor.authorInitials |
Alvarez-Moreno, C |
dc.contributor.authorInitials |
Madani, N |
dc.contributor.authorInitials |
Mitrev, Z |
dc.contributor.authorInitials |
Ye, GX |
dc.contributor.authorInitials |
Salomao, R |
dc.contributor.authorInitials |
Ulger, F |
dc.contributor.authorInitials |
Guanche-Garcell, H |
dc.contributor.authorInitials |
Kanj, SS |
dc.contributor.authorInitials |
Cuellar, LE |
dc.contributor.authorInitials |
Higuera, F |
dc.contributor.authorInitials |
Mapp, T |
dc.contributor.authorInitials |
Fernandez-Hidalgo, R |
dc.contributor.authorOrcidID |
|
dc.contributor.authorReprintAddress |
Rosenthal, VD (reprint author), Int Nosocomial Infect Control Consortium, Infect Control Dept, Buenos Aires, DF, Argentina. |
dc.contributor.authorResearcherID |
|
dc.contributor.authorUniversity |
American University of Beirut Medical Center |
dc.description.cited |
Arabi Y, 2008, INT J INFECT DIS, V12, P505, DOI 10.1016-j.ijid.2008.02.010; Assanasen S, 2008, AM J INFECT CONTROL, V36, P407, DOI 10.1016-j.ajic.2007.08.008; Barba EJR, 2006, AM J INFECT CONTROL, V34, P244, DOI 10.1016-j.ajic.2005.05-024; Boyce JM, 2002, AM J INFECT CONTROL, V30, pS1, DOI 10.1067-mic.2002.130391; BOYCE JM, 1985, AM J INFECT CONTROL, V13, P228, DOI 10.1016-0196-6553(85)90063-X; Burns KEA, 2003, COCHRANE DB SYST REV, DOI [10.1002-14651858.CD004127, DOI 10.1002-14651858.CD004127]; Coffin SE, 2008, INFECT CONT HOSP EP, V29, pS31, DOI 10.1086-591062; Cook Deborah J., 1996, JAMA (Journal of the American Medical Association), V275, P308, DOI 10.1001-jama.275.4.308; Cuellar LE, 2008, REV PANAM SALUD PUBL, V24, P16, DOI 10.1590-S1020-49892008000700002; Dellinger RP, 2005, CRIT CARE, V9, P653, DOI 10.1186-cc3952; EMORI TG, 1991, AM J INFECT CONTROL, V19, P19, DOI 10.1016-0196-6553(91)90157-8; Gaynes RP, 1996, JOINT COMM J QUAL IM, V22, P457; Guanche-Garcell H, 2011, INT J INFECT DIS, V15, pE357, DOI 10.1016-j.ijid.2011.02.001; Heyland DK, 2001, CRIT CARE MED, V29, P1495, DOI 10.1097-00003246-200108000-00001; Higuera F, 2005, CRIT CARE MED, V33, P2022, DOI 10.1097-01.CCM.0000178190.89663.E5; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016-j.ajic.2008.03.002; HUGHES JM, 1988, CHEMOTHERAPY, V34, P553; KELLEGHAN SI, 1993, AM J INFECT CONTROL, V21, P322, DOI 10.1016-0196-6553(93)90390-P; KOLLEF MH, 1993, JAMA-J AM MED ASSOC, V270, P1965, DOI 10.1001-jama.270.16.1965; Kollef MH, 2004, CRIT CARE MED, V32, P1396, DOI 10.1097-01.CCM.0000128569.09113.FB; KOLLEF MH, 1995, ANN INTERN MED, V123, P168; Leblebicioglu H, 2007, J HOSP INFECT, V65, P251, DOI 10.1016-j.jhin.2006.10.012; Lynch P, 2007, BENNETT BRACHMANS HO, P255; Madani Naoufel, 2009, Int Arch Med, V2, P29, DOI 10.1186-1755-7682-2-29; Mehta A, 2007, J HOSP INFECT, V67, P168, DOI 10.1016-j.jhin.2007.07.008; Moreno CA, 2006, INFECT CONT HOSP EP, V27, P349, DOI 10.1086-503341; Panknin Hardy-Thorsten, 2006, Pflege Z, V59, P2; Rello J, 1996, AM J RESP CRIT CARE, V154, P111; Rosenthal VD, 2006, ANN INTERN MED, V145, P582; Rosenthal VD, 2011, LANCET, V377, P186, DOI 10.1016-S0140-6736(10)62005-3; Rosenthal VD, 2004, INFECT CONT HOSP EP, V25, P47, DOI 10.1086-502291; Rosenthal VD, 2008, AM J INFECT CONTROL, V36, P627, DOI 10.1016-j.ajic.2008.03.003; Rosenthal VD, 2010, AM J INFECT CONTROL, V38, P95, DOI 10.1016-j.ajic.2009.12.004; Rosenthal VD, 2008, AM J INFECT CONTROL, V36; Rosenthal VD, 2004, INFECT CONT HOSP EP, V25, P251, DOI 10.1086-502386; Rosenthal Victor D, 2008, Am J Infect Control, V36, pe1, DOI 10.1016-j.ajic.2008.06.003; Rosenthal VD, 2003, AM J INFECT CONTROL, V31, P85, DOI 10.1067-mic.2003.63; Rosenthal VD, 2010, INFECT CONT HOSP EP, V31, P1264, DOI 10.1086-657140; Rosenthal VD, 2003, AM J INFECT CONTROL, V31, P291, DOI 10.1067-mic.2003.1; Rosenthal VD, 2011, EPIDEMIOL INFECT, V139, P1757, DOI 10.1017-S0950268811000094; Rosenthal VD, 2005, AM J INFECT CONTROL, V33, P157, DOI 10.1016-j.ajic.2004.08.008; Rosenthal VD, 2006, AM J INFECT CONTROL, V34, P58, DOI 10.1016-j.ajic.2005.11.002; Rosenthal VD, 2003, AM J INFECT CONTROL, V31, P405, DOI 10.1067-mic.2003.52; Rosenthal VD, 2005, AM J INFECT CONTROL, V33, P392, DOI 10.1016-j.ajic.2004.08.009; Salomao R, 2008, REV PANAM SALUD PUBL, V24, P195, DOI 10.1590-S1020-49892008000900006; SALORD F, 1990, INTENS CARE MED, V16, P390, DOI 10.1007-BF01735177; Sax H, 2009, AM J INFECT CONTROL, V37, P827, DOI 10.1016-j.ajic.2009.07.003; Tablan Ofelia C, 2004, MMWR Recomm Rep, V53, P1; Tantipong H, 2008, INFECT CONT HOSP EP, V29, P131, DOI 10.1086-526438; Youngquist Paul, 2007, Jt Comm J Qual Patient Saf, V33, P219 |
dc.description.citedCount |
22 |
dc.description.citedTotWOSCount |
28 |
dc.description.citedWOSCount |
27 |
dc.format.extentCount |
8 |
dc.identifier.articleNo |
|
dc.identifier.coden |
CCMDC |
dc.identifier.pubmedID |
22975890 |
dc.identifier.scopusID |
84870242875 |
dc.identifier.url |
|
dc.publisher.address |
530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA |
dc.relation.ispartofConference |
|
dc.relation.ispartofConferenceCode |
|
dc.relation.ispartofConferenceDate |
|
dc.relation.ispartofConferenceHosting |
|
dc.relation.ispartofConferenceLoc |
|
dc.relation.ispartofConferenceSponsor |
|
dc.relation.ispartofConferenceTitle |
|
dc.relation.ispartofFundingAgency |
|
dc.relation.ispartOfISOAbbr |
Crit. Care Med. |
dc.relation.ispartOfIssue |
12 |
dc.relation.ispartOfPart |
|
dc.relation.ispartofPubTitle |
Critical Care Medicine |
dc.relation.ispartofPubTitleAbbr |
Crit. Care Med. |
dc.relation.ispartOfSpecialIssue |
|
dc.relation.ispartOfSuppl |
|
dc.relation.ispartOfVolume |
40 |
dc.source.ID |
WOS:000311427100001 |
dc.type.publication |
Journal |
dc.subject.otherAuthKeyword |
developing countries |
dc.subject.otherAuthKeyword |
intensive care unit |
dc.subject.otherAuthKeyword |
international multidimensional approach |
dc.subject.otherAuthKeyword |
International Nosocomial Infection Control Consortium |
dc.subject.otherAuthKeyword |
ventilator-associated pneumonia |
dc.subject.otherChemCAS |
ceftriaxone, 73384-59-5, 74578-69-1 |
dc.subject.otherChemCAS |
ciprofloxacin, 85721-33-1 |
dc.subject.otherChemCAS |
imipenem, 64221-86-9 |
dc.subject.otherChemCAS |
meticillin, 132-92-3, 38882-79-0, 61-32-5 |
dc.subject.otherIndex |
antibiotic agent |
dc.subject.otherIndex |
ceftriaxone |
dc.subject.otherIndex |
ciprofloxacin |
dc.subject.otherIndex |
imipenem |
dc.subject.otherIndex |
meticillin |
dc.subject.otherIndex |
piperacillin plus tazobactam |
dc.subject.otherIndex |
quinolone derivative |
dc.subject.otherIndex |
Acinetobacter |
dc.subject.otherIndex |
adult |
dc.subject.otherIndex |
antibiotic resistance |
dc.subject.otherIndex |
article |
dc.subject.otherIndex |
artificial ventilation |
dc.subject.otherIndex |
developing country |
dc.subject.otherIndex |
disease severity |
dc.subject.otherIndex |
female |
dc.subject.otherIndex |
hospital patient |
dc.subject.otherIndex |
hospital personnel |
dc.subject.otherIndex |
human |
dc.subject.otherIndex |
infection control |
dc.subject.otherIndex |
intensive care unit |
dc.subject.otherIndex |
major clinical study |
dc.subject.otherIndex |
male |
dc.subject.otherIndex |
priority journal |
dc.subject.otherIndex |
prospective study |
dc.subject.otherIndex |
risk factor |
dc.subject.otherIndex |
Staphylococcus aureus |
dc.subject.otherIndex |
ventilator associated pneumonia |
dc.subject.otherIndex |
Adult |
dc.subject.otherIndex |
Aged |
dc.subject.otherIndex |
Cohort Studies |
dc.subject.otherIndex |
Cross Infection |
dc.subject.otherIndex |
Developing Countries |
dc.subject.otherIndex |
Female |
dc.subject.otherIndex |
Humans |
dc.subject.otherIndex |
Infection Control |
dc.subject.otherIndex |
Intensive Care Units |
dc.subject.otherIndex |
Male |
dc.subject.otherIndex |
Middle Aged |
dc.subject.otherIndex |
Pneumonia, Ventilator-Associated |
dc.subject.otherIndex |
Population Surveillance |
dc.subject.otherIndex |
Program Evaluation |
dc.subject.otherIndex |
Prospective Studies |
dc.subject.otherKeywordPlus |
RANDOMIZED CONTROLLED-TRIAL |
dc.subject.otherKeywordPlus |
BLOOD-STREAM INFECTIONS |
dc.subject.otherKeywordPlus |
LENGTH-OF-STAY |
dc.subject.otherKeywordPlus |
PERFORMANCE FEEDBACK |
dc.subject.otherKeywordPlus |
HAND HYGIENE |
dc.subject.otherKeywordPlus |
MECHANICAL VENTILATION |
dc.subject.otherKeywordPlus |
ARGENTINEAN HOSPITALS |
dc.subject.otherKeywordPlus |
CONTROL PROGRAM |
dc.subject.otherKeywordPlus |
RATES |
dc.subject.otherKeywordPlus |
INICC |
dc.subject.otherWOS |
Critical Care Medicine |